Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, read with Para A of Schedule III thereto, Concord Biotech has informed that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30 September, 2024, scheduled on Tuesday, 12th November, 2024 at 03:30 pm IST. The conference/Earning Call Invitation is enclosed.
The above information is a part of company’s filings submitted to BSE.
